Clinical Trend of the Week (February 11 - 17): Pancreatic Cancer
A complex connection with another condition resulted in this week's top search term. A European study of more than 550,000 patients with type 2 diabetes found that receiving glucagonlike peptide-1 (GLP-1) receptor agonists, or insulin mimetics, was associated with an increased risk of developing pancreatic cancer. However, the findings also suggest that the risk diminished rapidly after diagnosis. Additionally, "reverse causation" is a possibility, as asymptomatic pancreatic cancer that initially caused diabetes prior to progressing to a symptomatic state may be at work. Given this complicated association, it's no wonder that the top search term, "pancreatic cancer," was followed by "diabetes" in terms of popularity this week.
For more information on pancreatic cancer, read here.
Medscape © 2017
Cite this: Ryan Syrek. Clinical Trends for February 2017 - Medscape - Feb 24, 2017.